Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ischemic Stroke ll: Pathophysiology

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

Ischemic Stroke l: Introduction

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.

Transient Ischemic Attack l: Introduction

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...

Hemorrhagic Stroke ll: Pathophysiology

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of Lipoprotein (a) on the Quantification of LDL-Cholesterol.

Clinical laboratory·2026

Same author

Spacecraft sample collection and subsurface excavation of asteroid (101955) Bennu.

Science (New York, N.Y.)·2022

Same author

Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments.

Multiple sclerosis and related disorders·2022

Same author

Variations in color and reflectance on the surface of asteroid (101955) Bennu.

Science (New York, N.Y.)·2020

Same author

Episodes of particle ejection from the surface of the active asteroid (101955) Bennu.

Science (New York, N.Y.)·2019

Same author

The unexpected surface of asteroid (101955) Bennu.

Nature·2019

Same journal

Editorial.

Acta neurologica Scandinavica·2022

Same journal

Advances in sudden unexpected death in epilepsy.

Acta neurologica Scandinavica·2022

Same journal

Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.

Acta neurologica Scandinavica·2022

Same journal

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.

Acta neurologica Scandinavica·2022

Same journal

Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.

Acta neurologica Scandinavica·2022

Same journal

Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.

Acta neurologica Scandinavica·2022

See all related articles

Search research articles

Related Experiment Video

Updated: May 9, 2026

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

Immunological consequences of ischemic stroke.

A Vogelgesang¹, K J Becker, A Dressel

¹Universitiy Medicine, Institute of Immunology and Transfusion Medicine, Greifswald, Germany.

Acta Neurologica Scandinavica

|July 16, 2013

Summary

This summary is machine-generated.

Stroke impairs the immune system, increasing infection risk and worsening outcomes. Targeting these immune changes, particularly stress hormone effects, may offer new therapeutic strategies for ischemic stroke patients.

Keywords:

autoimmunity cerebrovascular diseases experimental stroke immunology infections stroke stroke associated infections

More Related Videos

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

Related Experiment Videos

Last Updated: May 9, 2026

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

Area of Science:

Neurology
Immunology
Pathophysiology

Background:

Ischemic stroke presents significant challenges in neurological treatment.
Stroke impacts both the central nervous system and systemic immune function.
Local inflammation at the infarct site exacerbates brain lesion development.

Purpose of the Study:

To review the immunological consequences of ischemic stroke.
To explore the link between peripheral immune suppression and local inflammation.
To discuss potential therapeutic strategies targeting stroke-induced immune alterations.

Main Methods:

Review of experimental stroke models and clinical observations.
Analysis of immune cell function (lymphocytes, monocytes) in stroke patients.
Investigation of the role of stress hormones (catecholamines, steroids) in immune modulation.

Main Results:

Stroke induces local brain inflammation and peripheral immune suppression (lymphocytopenia, monocyte dysfunction).
Immune suppression increases the risk of post-stroke infections.
Pharmacological inhibition of beta-adrenergic receptors, not steroids, improved outcomes in experimental stroke, implicating catecholamines.

Conclusions:

Immune alterations significantly impact the clinical course of ischemic stroke.
Targeting stroke-induced immune suppression is a promising therapeutic avenue.
Translating experimental findings into clinical trials remains a challenge.